Nonpharmacological Treatment of Atrial Fibrillation: What Is the Role of Device Therapy?

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11130%2F20%3A10411846" target="_blank" >RIV/00216208:11130/20:10411846 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00064203:_____/20:10411846

Výsledek na webu

<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=b3Bm7LKhnS" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=b3Bm7LKhnS</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1055/s-0040-1708529" target="_blank" >10.1055/s-0040-1708529</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Nonpharmacological Treatment of Atrial Fibrillation: What Is the Role of Device Therapy?

Popis výsledku v původním jazyce

Atrial fibrillation is the most common arrhythmia in the adult population, and its incidence and prevalence are still rising. Cardiac devices are widely used in clinical practice in the management of various rhythm disturbances and heart failure treatment. Many patients who receive a pacemaker, implantable cardioverter-defibrillator, or cardiac resynchronization therapy also experience atrial fibrillation in the course of their life. Therefore, this review aims to describe the role of these devices in the treatment and prevention of atrial fibrillation in the device recipients. In addition, all these implantable devices also serve as permanent ECG (electrocardiogram) monitors, thus providing important information about the presence and characteristics of atrial fibrillation that may or may not be detected by the patient but can modify our therapeutical approach with regard to the stroke prevention.

Název v anglickém jazyce

Nonpharmacological Treatment of Atrial Fibrillation: What Is the Role of Device Therapy?

Popis výsledku anglicky

Atrial fibrillation is the most common arrhythmia in the adult population, and its incidence and prevalence are still rising. Cardiac devices are widely used in clinical practice in the management of various rhythm disturbances and heart failure treatment. Many patients who receive a pacemaker, implantable cardioverter-defibrillator, or cardiac resynchronization therapy also experience atrial fibrillation in the course of their life. Therefore, this review aims to describe the role of these devices in the treatment and prevention of atrial fibrillation in the device recipients. In addition, all these implantable devices also serve as permanent ECG (electrocardiogram) monitors, thus providing important information about the presence and characteristics of atrial fibrillation that may or may not be detected by the patient but can modify our therapeutical approach with regard to the stroke prevention.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30201 - Cardiac and Cardiovascular systems

Projekt

<a href="/cs/project/NV15-31398A" target="_blank" >NV15-31398A: Charakteristiky elektromechanické dyssynchronie predikující efekt srdeční resynchronizační terapie</a><br>

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2020

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

International Journal of Angiology

ISSN

1061-1711

e-ISSN

—

Svazek periodika

29

Číslo periodika v rámci svazku

2

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

10

Strana od-do

113-122

Kód UT WoS článku

000538104900006

EID výsledku v databázi Scopus

2-s2.0-85086004502